Technical Analysis for ACET - Adicet Bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Volume Surge | Other | -2.50% | |
Wide Bands | Range Expansion | -2.50% | |
Down 3 Days in a Row | Weakness | -2.50% |
Alert | Time |
---|---|
Up 2% | about 12 hours ago |
60 Minute Opening Range Breakout | about 12 hours ago |
Up 1% | about 12 hours ago |
Lower Bollinger Band Support | about 14 hours ago |
Down 5% | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/13/2024
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell T Cell Chimeric Antigen Receptor Therapies For Cancer Adoptive Cell Transfer Antigen Immune Response
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell T Cell Chimeric Antigen Receptor Therapies For Cancer Adoptive Cell Transfer Antigen Immune Response
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.5 |
52 Week Low | 1.1 |
Average Volume | 1,899,279 |
200-Day Moving Average | 2.29 |
50-Day Moving Average | 2.69 |
20-Day Moving Average | 2.37 |
10-Day Moving Average | 2.26 |
Average True Range | 0.20 |
RSI (14) | 30.07 |
ADX | 18.28 |
+DI | 15.17 |
-DI | 29.62 |
Chandelier Exit (Long, 3 ATRs) | 2.45 |
Chandelier Exit (Short, 3 ATRs) | 2.47 |
Upper Bollinger Bands | 2.77 |
Lower Bollinger Band | 1.97 |
Percent B (%b) | -0.02 |
BandWidth | 33.79 |
MACD Line | -0.16 |
MACD Signal Line | -0.11 |
MACD Histogram | -0.0486 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.22 | ||||
Resistance 3 (R3) | 2.23 | 2.14 | 2.18 | ||
Resistance 2 (R2) | 2.14 | 2.07 | 2.14 | 2.16 | |
Resistance 1 (R1) | 2.05 | 2.03 | 2.01 | 2.04 | 2.14 |
Pivot Point | 1.96 | 1.96 | 1.94 | 1.96 | 1.96 |
Support 1 (S1) | 1.87 | 1.89 | 1.83 | 1.86 | 1.76 |
Support 2 (S2) | 1.78 | 1.85 | 1.78 | 1.74 | |
Support 3 (S3) | 1.69 | 1.78 | 1.73 | ||
Support 4 (S4) | 1.68 |